Trump proposal would have hospitals make more drugs in-house
The partnership with top health agencies and companies like Mark Cuban's Cost Plus Drug Company aims to use AI to produce drugs at care sites.
The partnership with top health agencies and companies like Mark Cuban's Cost Plus Drug Company aims to use AI to produce drugs at care sites.
Digital health investors are shifting their focus to a select number of companies with sustainable business models.
Executive recruiting firms report a sharp decline in interest in diversity, equity and inclusion hiring initiatives within the healthcare sector.
Multiple artificial intelligence-related companies secured deals this week.
A group of 120 accountable care organizations say an ongoing problem with savings targets could substantially cost providers.
Catch up on what you need to read to finish your week.
The letter follow the filing of a lawsuit against The Leapfrog Group late last month.
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
CommonSpirit Health recorded a $42 million net loss in its third quarter, compared with $282 million in net income a year ago.
The Yellowstone High Value Network in Montana aims to improve care models at independent rural hospitals while reducing costs.
Quick Health is accused of signing up tens of thousands of customers for cheap, bare-bones health plans using “false, misleading, and deceptive sales practices.”